Valero Energy Corporation (VLO) has significantly outperformed the broader market and the energy sector over the past year, with its stock rallying 80.9%. The company recently reported Q1 results that exceeded analyst expectations, showing a 7% year-over-year revenue growth and higher-than-anticipated EPS. Wall Street analysts maintain a "Moderate Buy" consensus rating for VLO, with a mean price target suggesting a modest upside from current levels, and some analysts predicting a potential upside of over 22%.

The European Commission has approved Pfizer's HYMPAVZI (marstacimab) to expand its indication for adults and adolescents aged 12 and older with hemophilia A or B who have inhibitors. This once-weekly subcutaneous treatment demonstrated superior bleed reduction compared to on-demand therapy in Phase 3 trials and is the only medicine approved in the EU for both hemophilia A and B with or without inhibitors. The approval provides a new critical treatment option for patients whose traditional factor replacement therapies are ineffective due to inhibitor development.

Mid-America Technology Center (MATC) has recognized CVR Energy, Inc. as its 2026 Partner in Progress, honoring the company's commitment to workforce development, community partnership, and educational advancement. CVR Energy has played a vital role in MATC's Professional Resource Outreach programs, notably contributing $80,000 in 2025 to launch the CVR Energy, Inc. District 8 Hub Store, which provides essential support to students facing financial barriers. This partnership exemplifies a strong collaboration that drives progress in the Mid-America district.

This article provides financial information for Cullen/Frost Bankers, Inc. Depositary Shares (NYSE: CFR/PB), specifically focusing on the ratio of savings deposits to total deposits. It identifies the security as representing a 1/40th ownership interest in a share of 4.450% non-cumulative perpetual preferred stock, Series. The content is presented within the context of a financial data platform, highlighting market status and financial metrics.

Concord Healthcare Group Co., Ltd., a subsidiary of Concord Medical Services Holdings Ltd, has issued HK$68 million in 2% convertible bonds due 2027. The transaction involved Haitong International Securities Company Limited as the placing agent and Dragon Merit Holdings Limited as the subscriber. This issuance follows the listing of Concord Healthcare’s H shares on the Main Board of The Stock Exchange of Hong Kong Limited on January 9, 2024.

ClearPoint Neuro, Inc. announced strong financial results for the first quarter of 2026, achieving record revenue of $12.1 million, driven by 43% overall growth and 25% organic growth in devices. The company highlighted significant strategic progress across its four-pillar growth strategy, including expansion of its global installed base, FDA clearance for a new surgical drill system, and successful integration of the IRRAflow product portfolio. ClearPoint Neuro also provided optimistic guidance for 2026, estimating total revenue between $52.0 million and $56.0 million, and expects cost synergies from the IRRAS acquisition to reduce cash burn.

Bitwise's BSOL ETF is dominating the US Solana ETF market, capturing 81% of daily inflows ($21.6 million out of $26.57 million) and 78% of year-to-date inflows (roughly $1 billion). Its appeal stems from offering direct SOL exposure with staking rewards, which institutions prefer due to regulatory compliance, simpler custody, and tax reporting. This trend suggests strong and sustained institutional demand for Solana.

Nvidia CEO Jensen Huang and his wife Lori's foundation is donating $108.3 million worth of computing time from CoreWeave to universities and other nonprofit institutes for science and AI research. This initiative includes free engineering services from Nvidia for some grant recipients. The donation also highlights Nvidia's continued support for CoreWeave, a cloud computing company specializing in AI applications, following Nvidia's previous investment and a $6.3 billion deal for cloud computing capacity.

Camtek Ltd (CAMT) shares recently dropped 3.3% to $168.88, yet the stock is considered significantly overvalued according to GuruFocus' GF Value, which estimates its fair value at $102.70. Despite the overvaluation and historical P/E ratios being much higher than its 5-year median, CAMT boasts an impressive GF Score of 90/100, driven by strong growth and profitability ratings. There have been no insider transactions reported in the last three months, suggesting a cautious stance or confidence among executives.

B93.7 is hosting a contest for a $250 gift card to Bob's Discount Furniture to celebrate the grand opening of their new Spartanburg showroom. The grand opening will take place from May 22nd to May 24th, with B9.37's Torry on-site on Sunday, May 24th. In addition to the contest, Bob's will donate $2,500 to a local nonprofit and school.